HUMAN IMMUNE SYSTEM IN A DISH

Serial Number 97239138
733

Registration Progress

Application Filed
Jan 26, 2022
Under Examination
Jun 13, 2023
Approved for Publication
Oct 25, 2022
Published for Opposition
Oct 25, 2022
Registered

Trademark Image

HUMAN IMMUNE SYSTEM IN A DISH

Basic Information

Serial Number
97239138
Filing Date
January 26, 2022
Published for Opposition
October 25, 2022
Drawing Code
4

Status Summary

Current Status
Active
Status Code
733
Status Date
Jun 6, 2025
Application
Pending
Classes
005 042

Rights Holder

Parallel Biosystems, Inc.

03
Address
750 Main Street
Cambridge, MA 02139

Ownership History

Parallel Biosystems, Inc.

Original Applicant
03
Torrance, CA

Parallel Biosystems, Inc.

Owner at Publication
03
Cambridge, MA

Legal Representation

Attorney
Karen Won

USPTO Deadlines

All Deadlines Cleared

All 1 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

40 events
Date Code Type Description Documents
Dec 15, 2025 EISU I TEAS STATEMENT OF USE RECEIVED Loading...
Dec 15, 2025 ERTD I TEAS REQUEST TO DIVIDE RECEIVED Loading...
Dec 15, 2025 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Dec 14, 2025 ERTD I TEAS REQUEST TO DIVIDE RECEIVED Loading...
Sep 15, 2025 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jun 6, 2025 EX4G S SOU EXTENSION 4 GRANTED Loading...
Jun 6, 2025 EXT4 S SOU EXTENSION 4 FILED Loading...
Jun 6, 2025 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Mar 3, 2025 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Dec 6, 2024 EX3G S SOU EXTENSION 3 GRANTED Loading...
Dec 5, 2024 EXT3 S SOU EXTENSION 3 FILED Loading...
Dec 5, 2024 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jun 11, 2024 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jun 12, 2024 EX2G S SOU EXTENSION 2 GRANTED Loading...
Jun 12, 2024 EXT2 S SOU EXTENSION 2 FILED Loading...
Jun 11, 2024 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Dec 13, 2023 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Dec 11, 2023 EX1G S SOU EXTENSION 1 GRANTED Loading...
Dec 11, 2023 EXT1 S SOU EXTENSION 1 FILED Loading...
Dec 11, 2023 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Dec 11, 2023 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Dec 11, 2023 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
Dec 11, 2023 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED Loading...
Jun 13, 2023 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
May 4, 2023 ETOP T EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED Loading...
Nov 22, 2022 ETOF T EXTENSION OF TIME TO OPPOSE RECEIVED Loading...
Oct 25, 2022 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Oct 25, 2022 PUBO A PUBLISHED FOR OPPOSITION Loading...
Oct 5, 2022 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Sep 20, 2022 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Sep 20, 2022 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Sep 20, 2022 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Sep 20, 2022 GNEA O EXAMINERS AMENDMENT E-MAILED Loading...
Sep 20, 2022 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Sep 19, 2022 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Sep 19, 2022 GNRT F NON-FINAL ACTION E-MAILED Loading...
Sep 19, 2022 CNRT R NON-FINAL ACTION WRITTEN Loading...
Sep 14, 2022 DOCK D ASSIGNED TO EXAMINER Loading...
Jan 31, 2022 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Jan 29, 2022 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical and biologic preparations for use in oncology, immunology, and cell degeneration; Pharmaceutical preparations, namely, therapeutic agents, immunotherapies, antibody therapies, and cell therapies for the treatment of cancer, autoimmune diseases, degenerative diseases; Vaccines; Antibodies for medical and medical diagnostic laboratory use
Class 042
Medical scientific research testing, research and development services in the fields of immune organoids, immune system modeling, antibodies, pharmaceuticals, biologics, immunotherapies, and cell therapies; Drug discovery services; Biotechnology research and development services, namely, providing screening and analysis of immune responses, antibodies, human cells, and pharmaceutical and biologic therapies

Classification

International Classes
005 042